Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The difference between Hodgkin's lymphoma and Non-Hodgkin's lymphoma is that the cells of each of these diseases look different under a microscope. They also spread differently. Hodgkin's spreads in a more predictable way and not as much as non-Hodgkins.
In addition to Hodgkin's lymphoma and Non-Hodgkin's lymphoma, we are also a major referral center for patients with lymphomas that affect the skin:
One type is B lymphocytes, which are also called B cells.
The other type is T lymphocytes, which are also called T cells.
The main role of B cells is to protect the body against bacteria and viruses by producing proteins called antibodies. Antibodies attract other immune system cells and proteins that kill bacteria or viruses.
T cells have a variety of functions. Some protect the body by destroying virus-infected cells or by releasing substances that attract other types of white blood cells. Others help destroy some types of cancer cells.
Lymphoma can start in either B cells or T cells. Lab tests can help determine which type of cell the lymphoma has started in by seeing substances on the surface of the cells. Getting this information is an important first step in choosing the best treatment.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.